Alaunos Therapeutics Inc (FRA:WEK)
€ 1.41 0 (0%) Market Cap: 326.90 Mil Enterprise Value: 325.29 Mil PE Ratio: 0 PB Ratio: 1.08 GF Score: 60/100

ZIOPHARM Oncology Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 14, 2020 / 09:00PM GMT
Release Date Price: €2.58 (-0.77%)
Olivia Brayer;BofA Merrill Lynch;Analyst
Research Division

Great. So good afternoon, everyone, and welcome to our afternoon session of the BofA Virtual Las Vegas Healthcare Conference. My name is Olivia Brayer, and I'm on the U.S. biopharma team here at Bank of America. And we're very happy to have with us on the line the Chief Executive Officer of Ziopharm Oncology, Laurence Cooper; as well as President, David Mauney; and Chief Financial Officer, Sath Shukla. Guys, are you all there?

Laurence James Neil Cooper
ZIOPHARM Oncology, Inc. - CEO & Director

We are, Olivia. Thank you so much, and welcome.

David M. Mauney
ZIOPHARM Oncology, Inc. - President

Yes. We're here. Thank you.

Questions & Answers

Olivia Brayer;BofA Merrill Lynch;Analyst
Research Division

All right. Perfect. Great. So with that, I'll just dive right in. So Laurence, on a COVID-19 front, obviously, coronavirus has

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot